Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis

被引:33
作者
Alazzouzi, H
Domingo, E
González, S
Blanco, I
Armengol, M
Espín, E
Plaja, A
Schwartz, S
Capella, G
Schwartz, S
机构
[1] Hosp Univ Vall Hebron, Ctr Invest Bioquim & Biol Mol, Barcelona 08035, Spain
[2] Inst Catala Oncol, Translat Res Unit, Lhospitalet De Llobregat 08907, Spain
[3] Inst Catala Oncol, Genet Counseling Unit, Lhospitalet De Llobregat 08907, Spain
关键词
D O I
10.1093/hmg/ddi021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Microsatellite instability (MSI) characterizes tumors arising in patients with hereditary non-polyposis colorectal cancer (HNPCC) syndrome. HNPCC is a hereditary autosomal dominant disease caused by germline mutations in genes from the DNA (MMR) mismatch repair system. In these tumors, the loss of MMR compromises the genome integrity, allowing the progressive accumulation of mutations and the establishment of a mutator phenotype in a recessive manner. It is not clear, however, whether MSI can be detected in HNPCC carriers before tumor diagnosis. The aim of this study was to evaluate the presence of genetic instability in MMR gene carriers in peripheral blood lymphocytes of carriers and non-carriers members of two HNPCC families harboring a germline MLH1 and MSH2 mutation, respectively. An extensive analysis of the allelic distribution of single molecules of the polyA tract bat26 was performed using a highly sensitive PCR-cloning approach. In non-carriers, the allelic distribution of single bat26 molecules followed a gaussian distribution with no bat26 alleles shorter than (A)(21). All mutation carriers showed unstable alleles [(A)(20) or shorter] with an overall frequency of 5.6% (102/1814). We therefore suggest that low levels of genomic instability characterize MMR mutation carriers. These observations suggest that somatic mutations accumulate well before tumor diagnosis. Even though it is not clear whether this is due to the presence of a small percentage of cells with lost MMR or due to MMR haploinsufficiency, detection of these short unstable alleles might help in the identification of asymptomatic carriers belonging to families with no detectable MMR gene mutations.
引用
收藏
页码:235 / 239
页数:5
相关论文
共 30 条
  • [1] AALTONEN LA, 1994, CANCER RES, V54, P1645
  • [2] CLUES TO THE PATHOGENESIS OF FAMILIAL COLORECTAL-CANCER
    AALTONEN, LA
    PELTOMAKI, P
    LEACH, FS
    SISTONEN, P
    PYLKKANEN, L
    MECKLIN, JP
    JARVINEN, H
    POWELL, SM
    JEN, J
    HAMILTON, SR
    PETERSEN, GM
    KINZLER, KW
    VOGELSTEIN, B
    DELACHAPELLE, A
    [J]. SCIENCE, 1993, 260 (5109) : 812 - 816
  • [3] Germline mutations at microsatellite loci in homozygous and heterozygous mutants for mismatch repair and PCNA genes in Drosophila
    Baida, A
    López, A
    Marcos, R
    Velázquez, A
    [J]. DNA REPAIR, 2003, 2 (07) : 827 - 833
  • [4] Boland CR, 1998, CANCER RES, V58, P5248
  • [5] Colorectal pretumor progression before and after loss of DNA mismatch repair
    Calabrese, P
    Tsao, JL
    Yatabe, Y
    Salovaara, R
    Mecklin, JP
    Järvinen, HJ
    Aaltonen, LA
    Tavaré, S
    Shibata, D
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (04) : 1447 - 1453
  • [6] Casares S, 1995, ONCOGENE, V11, P2303
  • [7] Mutator phenotypes of yeast strains heterozygous for mutations in the MSH2 gene
    Drotschmann, K
    Clark, AB
    Tran, HT
    Resnick, MA
    Gordenin, DA
    Kunkel, TA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) : 2970 - 2975
  • [8] Mutator phenotype due to loss of heterozygosity in diploid yeast strains with mutations in MSH2 and MLH1
    Drotschmann, K
    Shcherbakova, PV
    Kunkel, TA
    [J]. TOXICOLOGY LETTERS, 2000, 112 : 239 - 244
  • [9] LOSS OF THE WILD-TYPE MLH1 GENE IS A FEATURE OF HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER
    HEMMINKI, A
    PELTOMAKI, P
    MECKLIN, JP
    JARVINEN, H
    SALOVAARA, R
    NYSTROMLAHTI, M
    DELACHAPELLE, A
    AALTONEN, LA
    [J]. NATURE GENETICS, 1994, 8 (04) : 405 - 410
  • [10] Hoang JM, 1997, CANCER RES, V57, P300